Bulletin de Périodique
Druglink , Vol.29, n°1 - January-February 2014 - Talking 'bout my generation (Older users)
Paru le :
01/02/2014
Année
2014
Page(s) :
31 p.
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
NEWS:
US welfare drug testing
Ketamine: the student drug
Government criticised over minimum pricing
Chinese meth raid
A CMD recovery report summary
FEATURES:
Special Issue: Older users
No silver lining: Gemma Lousley of DrugScope on the findings of our report on older users.
Head to head: A debate on whether the recover agenda is relevant to older users. By Rebecca Lees.
Deals on wheels: Max Daly investigates the phenomenon of the older recreational user.
A generation ignored: Jane Ward and Julia Sinclair describe Southampton's response to ageing users.
Coming of age: Erin O'Mara on the death of her friend, Chris Drouet.
The Druglink Interview: Harry Shapiro interviews Steve Rolles of Transform on their guide to cannabis legalisation.
Dane law: After 35 years of campaigning, Denmark now has drug consumption rooms. Could it happen in the UK? By Blaine Stothard.
Krokodil sinks teeth into Georgia. The harsh realities of a homemade heroin substitute. By Michael Bird.
REGULARS:
Research: how many drinkers should be in treatment?
Reviews:
Alex Stevens on the failure of US drug policy as seen by an American neuroscientist.
Lorna Templeton reviews an important guide for social workers on supporting those with dependency problems.
Factsheet: AMT, a legal psychedelic.
NEWS:
US welfare drug testing
Ketamine: the student drug
Government criticised over minimum pricing
Chinese meth raid
A CMD recovery report summary
FEATURES:
Special Issue: Older users
No silver lining: Gemma Lousley of DrugScope on the findings of our report on older users.
Head to head: A debate on whether the recover agenda is relevant to older users. By Rebecca Lees.
Deals on wheels: Max Daly investigates the phenomenon of the older recreational user.
A generation ignored: Jane Ward and Julia Sinclair describe Southampton's response to ageing users.
Coming of age: Erin O'Mara on the death of her friend, Chris Drouet.
The Druglink Interview: Harry Shapiro interviews Steve Rolles of Transform on their guide to cannabis legalisation.
Dane law: After 35 years of campaigning, Denmark now has drug consumption rooms. Could it happen in the UK? By Blaine Stothard.
Krokodil sinks teeth into Georgia. The harsh realities of a homemade heroin substitute. By Michael Bird.
REGULARS:
Research: how many drinkers should be in treatment?
Reviews:
Alex Stevens on the failure of US drug policy as seen by an American neuroscientist.
Lorna Templeton reviews an important guide for social workers on supporting those with dependency problems.
Factsheet: AMT, a legal psychedelic.
Dépouillements
Ajouter le résultat à votre sélection
Problematic drug and alcohol use among older people is on the rise and health services must adapt. Following a roundtable discussion on the issue last year, DrugScope is set to publish a major briefing on the subject.
The recovery agenda shifts the focus of treatment to a positive vision of wellbeing and freedom from dependence. But is it realistic for older people to expect a fulfilling life beyond drugs, or is it just a box ticking exercise? Rebecca Lees he[...]
The number of older recreational drug users appears to be on the rise. But who are they and why are they still taking drugs? Max Daly investigates.
J. WARD ;
J. SINCLAIR
|
2014
Dans Druglink (Vol.29, n°1, January-February 2014) Article : Périodique
Dans Druglink (Vol.29, n°1, January-February 2014) Article : Périodique
Although tackling alcohol use remains on the national agenda, many practitioners are aware they are only addressing the tip of the iceberg. Who is the main group missing from specialist services? It's the over-50s.
It took 35 years of campaigning for the authorities to accept drug consumption rooms in Denmark. Could it happen the UK?
The use of krokodil, a harsh homemade heroin alternative, is spreading from Russia to oppressed communities in Georgia. Michael Bird reports from Tbilisi.
Alpha-methyltryptamine (MT/AMT) is a currently legal new psychoactive substance. It is a long acting, synthetic psychedelic.
Historique